Business development for biotechnology and the pharmaceutical industry (Record no. 55014)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02137 a2200181 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240906b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-1-03-283793-2 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.1068/Aus |
| Item number | 38695 |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Austin, Martin |
| 9 (RLIN) | 39056 |
| 245 ## - TITLE STATEMENT | |
| Title | Business development for biotechnology and the pharmaceutical industry |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc | New York |
| Name of publisher, distributor, etc | Routledge |
| Date of publication, distribution, etc | 2008 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | xii, 186p. |
| Other physical details | Paperback |
| 505 ## - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Foreword; The role of business development; Planning the portfolio; Identifying the needs; Profiling and searching for opportunities; Modelling and valuation; Structuring the value; Due diligence and negotiations; Sealing the deal - the contract; Making the transaction work; Glossary; Index. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Business Development in the biotechnology and pharmaceutical industries accounts for over $5 billion in licensing deal value per year and much more than that in the value of mergers and acquisitions. Transactions range from licences to patented academic research, to product developments as licences, joint ventures and acquisition of intellectual property rights, and on to collaborations in development and marketing, locally or across the globe. Asset sales, mergers and corporate takeovers are also a part of the business development remit. The scope of the job can be immense, spanning the life-cycle of products from the earliest levels of research to the disposal of residual marketing rights, involving legal regulatory manufacturing, clinical development, sales and marketing and financial aspects. The knowledge and skills required of practitioners must be similarly broad, yet the availability of information for developing a career in business development is sparse. Martin Austin's highly practical guide spans the complete process and is based on his 30 years of experience in the industry and the well-established training programme that he has developed and delivers to pharmaceutical executives from across the world. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Biotechnologies industries, Pharmaceutical industry |
| 9 (RLIN) | 39143 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Item type | Book |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Source of acquisition | Cost, normal purchase price | Total Checkouts | Full call number | Barcode | Checked out | Date last seen | Date last borrowed | Cost, replacement price | Price effective from |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dewey Decimal Classification | Not For Loan | Main Library | Main Library | 29/08/2024 | 18 | 0.00 | 1 | 615.1068/Aus/38695 | 11138695 | 17/12/2024 | 18/09/2024 | 18/09/2024 | 4996.00 | 29/08/2024 |